In a research report released today, Brean Capital analyst Jonathan Aschoff reiterated a Sell rating on Rockwell Medical (NASDAQ:RMTI) with a $4 price target, …
In a research report published Wednesday, H.C.
In a research report sent to investors today, Roth Capital analyst Philip Shen reiterated a Buy rating on SolarCity (NASDAQ:SCTY) with a price …
In a research report released Monday, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Achillion Pharmaceuticals (NASDAQ:ACHN) with a $22 price …
In a research report published today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Inovio Pharmaceuticals (NASDAQ:INO) with a price target …
In a research report released today, Oppenheimer analyst Christopher Marai reiterated an Outperform rating on Celldex Therapeutics (NASDAQ:CLDX) with a $36 price target, …
In a research report released today, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Neostem (NASDAQ:NBS) with a $15 price target, which …
Roth Capital analyst Joseph Pantginis reiterated a Buy rating on Galena Biopharma (NASDAQ:GALE) with an $8 price target, as the company announced the expected initiation …
In a research report released Wednesday, MLV analyst George Zavoico reiterated a Buy rating on Peregrine Pharma (NASDAQ:PPHM) with a $3.50 price target, following presentation …
In a research report released today, Cantor analyst Irina Rivkind reiterated a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with an $8 price target, following the …
